Papers - HATAKEYAMA SHINGO
-
Preoperative prognostic model for localized and locally advanced renal cell carcinoma: Michinoku Japan Urological Cancer Study Group.
Horie S, Naito S, Hatakeyama S, Kandori S, Numakura K, Kato R, Koguchi T, Myoen S, Kawasaki Y, Ito A, Adachi H, Kojima Y, Obara W, Habuchi T, Nishiyama H, Ohyama C, Tsuchiya N.
2023.11
-
The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database.
Koguchi T, Naito S, Hatakeyama S, Numakura K, Muto Y, Kato R, Kojima T, Kawasaki Y, Morozumi K, Kandori S, Kawamura S, Nishiyama H, Ito A, Habuchi T, Obara W, Ohyama C, Tsuchiya N, Kojima Y.
2023.11
-
Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site.
Nishiyama N, Kita Y, Ito K, Kato M, Hatakeyama S, Matsushita Y, Naito S, Miyake M, Nakanishi S, Kato Y, Shibuya T, Hayashi T, Yasumoto H, Yoshida T, Uemura M, Taoka R, Nishiyama H, Kobayashi T, Kitamura H; Japan Urological Oncology Group.
2023.11
-
Humoral response to SARS-CoV-2 mRNA vaccine on in ABO blood type incompatible kidney transplant recipients treated with low-dose rituximab.
Hamaya T, Hatakeyama S, Yoneyama T, Tobisawa Y, Kodama H, Fujita T, Murakami R, Mori K, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Saitoh H, Narumi S, Tomita H, Ohyama C.
Sci Rep. 2023.9
-
学会印象記 「第110回日本泌尿器科学会総会」印象記
畠山 真吾
臨床泌尿器科 77 ( 9 ) 739 - 741 2023.8
-
Think different in urinary stone treatment 尿路結石形成の解明と治療への応用を目指して
畠山 真吾, 米山 徹, 大山 力
泌尿器外科 36 ( 臨増 ) 732 - 733 2023.8
-
「Stone freeを目指すための様々なアプローチ」 抗炎症作用に着目したアプローチ
阿南 剛, 廣瀬 卓男, 米山 徹, 菊池 大輔, 畠山 真吾, 佐藤 信, 森 建文, 大山 力
日本尿路結石症学会学術集会プログラム・抄録集 33回 33 - 33 2023.8
-
Primary resistance to nivolumab plus ipilimumab therapy in patients with metastatic renal cell carcinoma.
Numakura K, Sekine Y, Hatakeyama S, Muto Y, Sobu R, Kobayashi M, Sasagawa H, Kashima S, Yamamto R, Nara T, Akashi H, Tabata R, Sato S, Saito M, Narita S, Ohyama C, Habuchi T
Cancer medicine 2023.7
-
Trends in the use of local intervention for metastatic hormone-naïve prostate cancer: A multicenter retrospective study.
Tanaka R, Hatakeyama S, Narita S, Sakurai T, Tanaka T, Miura H, Oishi T, Kawamura S, Hoshi S, Ishidoya S, Mitsuzuka K, Ito A, Tsuchiya N, Habuchi T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 2023.7
-
Development and nationwide validation of kidney graft injury markers using urinary exosomes and microvesicles (complete English translation of the Japanese version).
Harada H, Fukuzawa N, Abe T, Imamura R, Masaki N, Fujiyama N, Sato S, Hatakeyama S, Nishimura K, Kishikawa H, Iwami D, Hotta K, Miura M, Ide K, Nakamura M, Kosoku A, Uchida J, Murakami T, Tsuji T
BMC nephrology 24 ( 1 ) 158 2023.6
-
Impact of nephroureterectomy on postoperative renal function in upper tract urothelial carcinoma: A multicenter retrospective study.
Okuyama Y, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka T, Fujita N, Okamoto T, Mori K, Yamamoto H, Yoneyama T, Hashimoto Y, Matsuoka T, Sato S, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 2023.5
-
Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era - a multi‑institutional retrospective study.
Renpei Kato, Sei Naito, Kazuyuki Numakura, Shingo Hatakeyama, Tomoyuki Koguchi, Takahiro Kojima, Yoshihide Kawasaki, Shuya Kandori, Sadafumi Kawamura, Yoichi Arai, Akihiro Ito, Hiroyuki Nishiyama, Yoshiyuki Kojima, Chikara Ohyama, Tomonori Habuchi, Norihiko Tsuchiya, Wataru Obara
International journal of clinical oncology 28 ( 5 ) 726 - 727 2023.5
-
Relationship between lower urinary tract symptoms and frailty.
Ozaki Y, Hatakeyama S, Imai A, Songee J, Soma O, Ozaki K, Fujita N, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 2023.4
-
Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study.
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
The world journal of men's health 41 ( 2 ) 373 - 381 2023.4
-
転移性ホルモン感受性前立腺癌に対するドセタキセルとアビラテロンの逐次療法の効果を含めた比較検討(Decetaxel versus Abiraterone for Metastatic Hormone-Sensitive Prostate Cancer with Focus on Efficacy of Sequential Therapy)
柳澤 孝文, 畠 憲一, 成田 伸太郎, 畠山 真吾, 森 啓一郎, 宮島 慶一朗, 江井 裕紀, 福岡屋 航, 松川 明弘, 三木 淳, 羽渕 友則, 大山 力, 木村 高弘
日本泌尿器科学会総会 110回 OP68 - 01 2023.4
-
Development of a minimally invasive medical system for urological malignancies for an aging society
Hirosaki Medical Journal 73 ( 1-4 ) 94 - 96 2023.3
-
特集 最新版! 筋層浸潤性膀胱癌の診断と治療-アンメットニーズはどこまで埋まったか 〈治療〉 筋層浸潤性膀胱癌に対する周術期全身療法-ネオアジュバント・アジュバント治療の進歩
畠山 真吾
臨床泌尿器科 77 ( 3 ) 226 - 233 2023.3
-
Trends in the age of hospitalized patients with urological cancers: A 17-year experience.
Ishii N, Hatakeyama S, Miura H, Tanaka R, Oishi T, Horiguchi H, Hosogoe S, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 2023.3
-
Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy.
Oishi T, Hatakeyama S, Tabata R, Fujimori D, Fukuda M, Shinozaki T, Ishii N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Sato S, Ohyama C
Scientific reports 13 ( 1 ) 3436 2023.3
-
Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.
Ozaki Y, Narita T, Hatakeyama S, Tanaka T, Togashi K, Hamaya T, Ozaki K, Ishi N, Oishi T, Tokui N, Mikami J, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Translational andrology and urology 12 ( 2 ) 161 - 167 2023.2